Zentek (ZTEKF) AI Stock Analysis

Zentek

(Other OTC:ZTEKF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low Financial LeverageModest leverage and meaningful equity provide Zentek with a financial cushion while it develops and commercializes its technologies. This reduces refinancing and solvency pressure over the next several quarters, although it does not eliminate the risk that continued losses gradually erode the equity base.

Negative Factors

Very Small and Declining RevenueExtremely low and declining revenue indicates that Zentek has not yet established meaningful commercial scale. Weak current traction limits internally generated funding, reduces operating leverage, and makes future performance highly dependent on converting development activities into sustained customer sales or licensing income.

Zentek (ZTEKF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $62.30M
Dividend Yield: ―
Average Volume (3M): 89.29K
Price to Earnings (P/E): -5.5
Beta (1Y): 1.10
Revenue Growth: -87.93%
EPS Growth: -14.03%
Country: US
Employees: 24
Sector: Basic Materials
Sector Strength: 61
Industry: Medical - Instruments & Supplies

Zentek Business Overview & Revenue Model

Company Description

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating u...

Zentek Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

ZTEKF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:MDP	63Neutral	CAD 154.93M	-46.24	-4.69%	―	-3.16%	-345.50%
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
TSE:ARCH	40Underperform	CAD 56.38M	-19.53	74.79%	―	―	-15.53%
TSE:BUX	40Underperform	CAD 50.05M	-34.81	-250.77%	―	-82.05%	23.73%
TSE:SONA	40Underperform	CAD 34.38M	-13.08	448.05%	―	―	24.65%

* Basic Materials Sector Average

Performance Comparison

ZTEKF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
ZTEKF	Zentek Ltd.	0.37	-0.45	-55.15%
TSE:ARCH	Arch Biopartners	0.83	-0.19	-18.63%
TSE:BUX	BioMark Diagnostics	0.47	0.13	38.24%
TSE:MDP	Medexus Pharmaceuticals	4.93	2.13	76.07%
TSE:SONA	Sona Nanotech, Inc	0.28	-0.33	-54.10%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Zentek AI Stock Analysis